CD37 and B-cell chronic lymphocytic leukemia: In particular, a higher number of serum CD19+MVs was reported in 11 CLL patients at diagnosis compared to healthy subjects [15], and an increased level of serum CD19+, CD20+ and CD37+MVs was described in advanced CLL compared to early-stage disease [70].